RV
Rachel Vatnsdal JP Morgan Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Henry Schein
HSIC
$8.22B
| $67.78 | $76 |
12%
upside
| Overweight | 28 days ago |
|
2
Adaptive Biotechnologies
ADPT
$1.98B
| $13.02 | $14 |
8%
upside
| Overweight | 29 days ago |
|
3
Avantor
AVTR
$8.99B
| $13.19 | $14 |
6%
upside
| Overweight | 1 month ago |
|
|
CAI
4
Caris Life Sciences, Inc. Common Stock
CAI
$10.2B
| $36.35 | $31 |
15%
downside
| Overweight | 1 month ago |
|
5
10x Genomics
TXG
$1.69B
| $13.57 | $9 |
34%
downside
| Neutral | 3 months ago |
|
6
Twist Bioscience
TWST
$1.55B
| $25.63 | $33 |
29%
upside
| Underweight | 4 months ago |
|
7
Repligen
RGEN
$6.78B
| $120.58 | $190 |
58%
upside
| Overweight | 4 months ago |
|
8
Revvity
RVTY
$9.95B
| $85.70 | $100 |
17%
upside
| Neutral | 4 months ago |
|
9
Envista
NVST
$3.45B
| $20.78 | $19 |
9%
downside
| Neutral | 6 months ago |
|
10
Waters Corp
WAT
$17.8B
| $299.69 | $390 |
30%
upside
| Neutral | 6 months ago |
|
|
TEM
11
Tempus AI, Inc. Class A Common Stock
TEM
$13.6B
| $78.12 | $55 |
30%
downside
| Neutral | 6 months ago |
|
12
Guardant Health
GH
$7.65B
| $61.36 | $55 |
10%
downside
| Overweight | 6 months ago |
|
13
Agilent Technologies
A
$36.4B
| $128.48 | $160 |
25%
upside
| Overweight | 9 months ago |
|
14
Thermo Fisher Scientific
TMO
$185B
| $489.49 | $670 |
37%
upside
| Overweight | 11 months ago |
|
15
Myriad Genetics
MYGN
$632M
| $6.79 | $20 |
195%
upside
| Underweight | 1 year ago |
|
16
Mettler-Toledo International
MTD
$26.5B
| $1,287.79 | $1,400 |
9%
upside
| Neutral | 1 year ago |
|
17
Bruker
BRKR
$4.52B
| $29.79 | $90 |
202%
upside
| Overweight | 1 year ago |
|
18
Danaher
DHR
$143B
| $199.03 | $270 |
36%
upside
| Overweight | 1 year ago |
|